American Well stock steadies after recent results as telehealth outlook stays mixed

Published on 09/19/2026 at 14:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

American Well stock is trading near recent lows after the company reported continued losses for the latest quarter in 2026 while growing its virtual-care revenue. Investors now weigh the telehealth group’s cash position and guidance against sector competition and slower demand.

AMWL, US03044L1052, Illustration mit AI erstellt.

American Well stock (ISIN US03044L1052) is trading near the lower end of its recent range as of September 19, 2026, with investors still digesting the company’s latest quarterly loss and telehealth growth figures from 2026.

Latest results frame American Well’s risk profile

The Boston-based telehealth provider American Well Corporation reported continued operating losses for its most recent fiscal period in 2026, while still growing revenue from virtual-care services compared with the prior year, according to company filings and investor materials available via its investor relations platform in 2026.

In the latest reported quarter of 2026, American Well’s revenue increased versus the comparable prior-year quarter, while the company still booked a net loss and negative EBITDA, reflecting ongoing investment in platform capabilities and sales. The figures for that quarter in 2026 show that revenue rose against the same quarter in 2025, but margins remained under pressure as operating expenses stayed high relative to sales, based on financial portal summaries of the 2026 quarterly release.

Telehealth growth meets competitive pressures

For investors, the key question now is how quickly American Well can narrow its losses while preserving revenue growth in a telehealth market that has normalized since the pandemic. Sector coverage in 2026 highlights that virtual-care demand no longer enjoys the exceptional surge seen in 2020-2021, and that providers such as American Well must compete more directly on functionality, integration with hospital systems and payer relationships.

Analyst commentary in 2026 describes sentiment on American Well stock as cautious, noting that the company’s cash position and runway remain important for equity holders while recurring revenue from health systems and payers continues to expand. The same coverage points to the company’s guidance indicating further investment in its platform and services, implying that profitability improvements may be gradual rather than immediate.

Stock trades near recent lows

As of the last completed trading day before September 19, 2026, American Well stock on its primary US exchange closed at a level that sits closer to its 52-week low than to its 52-week high, underscoring investor caution after the latest results. On that day in 2026, the shares finished the session with only a modest percentage move compared with the prior close, and trading volume remained relatively moderate for the stock.

Within the same 52-week window, the distance between American Well’s latest closing price and its 52-week high illustrates that the market has not yet fully rerated the telehealth group despite revenue growth, while the price stands above the 52-week low, indicating that the stock has at least stabilized after earlier declines. For retail investors, this combination of a still-lossmaking business, growing virtual-care revenue and a price closer to the 52-week low than the high is central to assessing the risk-reward profile.